Editas Medicine (EDIT) Enterprise Value: 2015-2025
Historic Enterprise Value for Editas Medicine (EDIT) over the last 11 years, with Sep 2025 value amounting to $146.4 million.
- Editas Medicine's Enterprise Value rose 805.97% to $146.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$523.0 million, marking a year-over-year increase of 40.72%. This contributed to the annual value of -$165.1 million for FY2024, which is 132.74% down from last year.
- As of Q3 2025, Editas Medicine's Enterprise Value stood at $146.4 million, which was up 2,482.80% from $5.7 million recorded in Q2 2025.
- Editas Medicine's Enterprise Value's 5-year high stood at $3.2 billion during Q2 2021, with a 5-year trough of -$165.1 million in Q4 2024.
- In the last 3 years, Editas Medicine's Enterprise Value had a median value of $135.9 million in 2023 and averaged $127.6 million.
- The largest annual percentage gain for Editas Medicine's Enterprise Value in the last 5 years was 805.97% (2025), contrasted with its biggest fall of 140.11% (2025).
- Editas Medicine's Enterprise Value (Quarterly) stood at $1.3 billion in 2021, then slumped by 79.82% to $265.7 million in 2022, then spiked by 89.81% to $504.2 million in 2023, then tumbled by 132.74% to -$165.1 million in 2024, then soared by 805.97% to $146.4 million in 2025.
- Its Enterprise Value stands at $146.4 million for Q3 2025, versus $5.7 million for Q2 2025 and -$124.7 million for Q1 2025.